Market Overview

UPDATE: Credit Suisse Reiterates Outperform Rating, Lowers PT on Express Scripts Holding Company

Share:
Related ESRX
Express Scripts Outlook Improves Amid Tax Reform, CVS-Aetna Deal
Benzinga's Top Upgrades, Downgrades For December 6, 2017
Advent International Corp Buys INC Research Holdings Inc, Envestnet Inc, Stericycle Inc, Sells ... (GuruFocus)

In a report published Wednesday, Credit Suisse reiterated its Outperform rating on Express Scripts Holding Company (NASDAQ: ESRX), but lowered its price target from $68.00 to $65.00.

Credit Suisse noted, “Following lower than expected initial comments regarding the 2013 economic and environmental outlook we believe the stock will find an intermediate-term home in the mid-$50 range. We believe that investors will look to grow comfortable with the industry's fundamentals and assess the potential conservatism of management's view on the economy & volumes before shares can move meaningfully higher. While we continue to struggle somewhat to reconcile ESRX's view of the market with the commentary from the company's main competitors and other supply chain peers, we continue to remain bullish on the intermediate-term opportunity for shares given the generic outlook, accretion from the deal synergies, and the strong cash flow characteristics of the business model.”

Express Scripts Holding Company closed on Tuesday at $55.18.

Latest Ratings for ESRX

DateFirmActionFromTo
Dec 2017BernsteinUpgradesUnderperformMarket Perform
Dec 2017Deutsche BankInitiates Coverage OnBuy
Oct 2017BairdMaintainsNeutral

View More Analyst Ratings for ESRX
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Price Target Analyst Ratings

 

Related Articles (ESRX)

View Comments and Join the Discussion!

Partner Center